Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-23

Clinical Trial Update: Probiotic Use in Patients With Prior COPD Exacerbation [NA]

View source ↗

Summary

A clinical trial investigating probiotic use in patients with prior COPD exacerbation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic therapy

Snippet

Sponsor: University of Oklahoma | Conditions: COPD, Obstructive Lung Disease | NA | Status: WITHDRAWN